Core Viewpoint - China's first prospective clinical trial of an invasive brain-computer interface (BCI) has been successfully conducted, making it the second country globally to enter the clinical trial phase after the United States [1] Group 1: Clinical Trial Details - The clinical trial's subject is a 37-year-old male who lost his limbs due to a high-voltage accident. Since the implantation of the BCI device in March, the system has operated stably without infections or electrode failures for over a month [3] - The subject has achieved a level of control over a computer touchpad comparable to that of a normal person, allowing him to play chess and racing games using only his thoughts after 2-3 weeks of adaptive training [3] Group 2: Technological Advancements - The implanted device is the smallest brain-controlled implant globally, measuring 26mm in diameter and less than 6mm in thickness, which is half the size of Neuralink's product [8] - The flexible neural electrodes developed by the research team are 1/5 to 1/7 the cross-sectional area of those used by Neuralink, providing better compatibility with brain tissue and reducing damage [5] Group 3: Research and Development - The research team has established a comprehensive approach to BCI research, covering various aspects such as motion perception, neural function repair, decoding algorithms, and wireless system development since 2022 [5] - The dynamic optimization of the neural decoder has been achieved through an online learning framework, allowing real-time motion decoding and overcoming the limitations of traditional static decoding models [9] Group 4: Future Prospects - The BCI system is expected to improve the quality of life for patients with complete spinal cord injuries, double upper limb amputations, and amyotrophic lateral sclerosis by enabling them to control external devices [12] - Future trials will aim to allow the subject to use robotic arms for physical tasks, expanding the potential applications of the technology [12]

以"开放合作：赋能新质生产力与可持续发展"为主题的第十一届中国（上海）国际技术进出口交易会于 6月11日至6月13日在上海举办。据悉，本届上交会聚焦"硬科技"与未来产业，展区汇聚了脑机接口、具 身智能、量子科技、合成生物等新赛道的多家企业，展示近百项突破性成果。 中国证券报记者在现场看到，上交会展区"黑科技"云集，全球首创的声镊单细胞分选技术、全球首展自 主研发的"月壤成纤"技术及装备等彰显实力的新技术和新产品集中亮相，描绘出未来科技产业的新图 景。 ● 本报记者 黄一灵 乔翔 自主创新成果不断涌现 中国证券报记者在现场深切感受到，在本届上交会上，自主创新成果不断涌现。 "在月球建立基地有助于更深入地对月球进行科研探索。目前，在月球上可以获取的材料很有限，从地 球向月球运输成本也很高。"东华大学博士生导师、先进玻璃制造技术教育部工程研究中心副主任汪庆 卫表示，"目前人类在月球上可以获取的材料只有月球土壤，但只有这一种材料是很难进行深度加工 的，如果可以把月球土壤做成纤维，可以为月球基地建设提供助力，这是我们想把月球土壤制成纤维的 一个主要出发点。" 中国证券报记者了解到，月球土壤是月球表面最主要的原位资源，如 ...

14家企业和机构将首发首展新产品、新技术，其中全球或全国首发的有7项。 "我原来是在高校做基础研究的，现在开始投身于应用，其实像我们高校的科研成果转化到市场还要涉及很多流程、手续，需要专业的机构来连 接。"在上交会长三角国创中心展台，来自华中师范大学的教授冯玲玲对第一财经说。 这并不是冯玲玲第一次来上海参加大型的展会，不过作为上交会的"萌新"选手，她还是希望借助该平台把他们的技术推向全国乃至世界。 和冯玲玲一样首次参加上交会的上海听介科技有限公司带来了混合智能通用设计平台，该公司创始人佘汀涛对记者说，除了希望通过上交会来认识 更多的投资人，还希望能接触到更多海外的客户，能带着他们的AI产品出海。 上交会的全称是中国（上海）国际技术进出口交易会，作为我国首个以技术作为展示和交易标的的国家级、国际性、综合性展会，6月11日~13日举 行的上交会也是技术贸易领域展示先进技术、链接创新资源、深化国际交流合作的重要平台。 "今年展会设4个专业技术展区，技术交易服务和技术交易促进活动2个功能区域，总展出面积3.5万平方米。14家企业和机构将首发首展新产品、新 技术，其中全球或全国首发的有7项。"上海市商务委主任朱民介绍。 ...